Gyre Therapeutics (GYRE) Cash from Operations Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 60.84% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 85.14% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -15.72% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 74.39% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 3.23% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 158.60% |
| 10 | Gyre Therapeutics | 532.38 Mn | 518.25 Mn | 8.38 Mn | 2,580.62% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2,580.62% |
| Dec 31, 2025 | -103.05% |
| Sep 30, 2025 | 166.51% |
| Jun 30, 2025 | 138.76% |
| Mar 31, 2025 | -104.47% |
| Dec 31, 2024 | -182.08% |
| Sep 30, 2024 | -77.24% |
| Jun 30, 2024 | -221.18% |
| Mar 31, 2024 | -72.31% |
| Dec 31, 2023 | -92.06% |
| Sep 30, 2023 | 204.19% |
| Jun 30, 2023 | 136.87% |
| Mar 31, 2023 | 186.45% |
| Dec 31, 2022 | 339.30% |
| Sep 30, 2022 | 66.31% |
| Jun 30, 2022 | 38.91% |
| Mar 31, 2022 | 50.53% |
| Dec 31, 2021 | 20.07% |
| Sep 30, 2021 | -66.05% |
| Jun 30, 2021 | -32.95% |
| Mar 31, 2021 | -408.48% |
| Dec 31, 2020 | -173.38% |
| Sep 30, 2020 | -42.95% |
| Jun 30, 2020 | -32.01% |
| Mar 31, 2020 | 67.98% |
| Dec 31, 2019 | 10.23% |
| Sep 30, 2019 | -29.59% |
| Jun 30, 2019 | -54.67% |
| Mar 31, 2019 | -192.89% |
| Dec 31, 2018 | -42.65% |
| Sep 30, 2018 | -42.46% |
| Jun 30, 2018 | -68.40% |
| Mar 31, 2018 | -18.99% |
| Dec 31, 2017 | -26.92% |
| Sep 30, 2017 | 3.52% |
| Jun 30, 2017 | -20.87% |
| Mar 31, 2017 | 9.53% |
| Dec 31, 2016 | 3.21% |
| Sep 30, 2016 | 46.94% |
| Jun 30, 2016 | -166.42% |
| Mar 31, 2016 | -59.19% |
| Dec 31, 2015 | -149.73% |
| Sep 30, 2015 | -149.56% |
| Jun 30, 2015 | 84.66% |
| Mar 31, 2015 | 79.93% |
| Dec 31, 2014 | -108.89% |
| Sep 30, 2014 | 300.11% |
| Jun 30, 2014 | 14.42% |
| Mar 31, 2014 | -59.29% |
| Dec 31, 2013 | 299.72% |
| Sep 30, 2013 | 6.67% |
| Jun 30, 2013 | 39.92% |
| Mar 31, 2013 | 62.57% |
| Dec 31, 2012 | 43.49% |
| Sep 30, 2012 | 42.46% |
| Jun 30, 2012 | 24.84% |
| Mar 31, 2012 | -12.95% |
| Dec 31, 2011 | -30.64% |
| Sep 30, 2011 | -6.43% |